Product Name
CEP290, Polyclonal Antibody
Full Product Name
CEP290 Antibody
Product Synonym Names
CT87; MKS4; POC3; rd16; BBS14; JBTS5; LCA10; NPHP6; SLSN6; 3H11Ag
Product Gene Name
anti-CEP290 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for O15078
Specificity
The antibody detects endogenous levels of total CEP290 protein.
Purity/Purification
Antigen affinity purification
Form/Format
In pH7.4 PBS, 0.05% NaN3, 40% Glycerol.
Concentration
0.7mg/ml (lot specific)
Immunogen
Synthetic protein corresponding to internal residues of human CEP290
Preparation and Storage
Store at -20 degree C.
Other Notes
Small volumes of anti-CEP290 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-CEP290 antibody
This gene encodes a protein with 13 putative coiled-coil domains, a region with homology to SMC chromosome segregation ATPases, six KID motifs, three tropomyosin homology domains and an ATP/GTP motif A. The protein is localized to the centrosome and cilia and has sites for N-glycosylation, tyrosine sulfation, phosphorylation, N-myristoylation, and amidation. Mutations in this gene have been associated with Joubert syndrome and nephronophthisis and the presence of antibodies against this protein is associated with several forms of cancer.
Product Categories/Family for anti-CEP290 antibody
Total protein Ab
Applications Tested/Suitable for anti-CEP290 antibody
Immunohistochemistry (IHC)
Application Notes for anti-CEP290 antibody
IHC: 1: 25-100
Immunohistochemistry (IHC) of anti-CEP290 antibody
The image on the left is immunohistochemistry of paraffin-embedded Human thyroid cancer tissue using 46475(CEP290 Antibody) at dilution 1/25, on the right is treated with fusion protein. (Original magnification: x200)

Immunohistochemistry (IHC) of anti-CEP290 antibody
The image on the left is immunohistochemistry of paraffin-embedded Human gastric cancer tissue using 46475(CEP290 Antibody) at dilution 1/25, on the right is treated with fusion protein. (Original magnification: x200)

NCBI/Uniprot data below describe general gene information for CEP290. It may not necessarily be applicable to this product.
NCBI Accession #
BC008641
[Other Products]
UniProt Primary Accession #
O15078
[Other Products]
UniProt Secondary Accession #
Q1PSK5; Q66GS8; Q9H2G6; Q9H6Q7; Q9H8I0[Other Products]
UniProt Related Accession #
O15078[Other Products]
Molecular Weight
180,067 Da
NCBI Official Full Name
Homo sapiens centrosomal protein 290kDa, mRNA
NCBI Official Synonym Full Names
centrosomal protein 290
NCBI Official Symbol
CEP290 [Similar Products]
NCBI Official Synonym Symbols
CT87; MKS4; POC3; rd16; BBS14; JBTS5; LCA10; NPHP6; SLSN6; 3H11Ag
[Similar Products]
NCBI Protein Information
centrosomal protein of 290 kDa
UniProt Protein Name
Centrosomal protein of 290 kDa
UniProt Synonym Protein Names
Bardet-Biedl syndrome 14 protein; Cancer/testis antigen 87; CT87; Nephrocystin-6; Tumor antigen se2-2
Protein Family
Centrosomal protein
UniProt Gene Name
CEP290 [Similar Products]
UniProt Synonym Gene Names
BBS14; KIAA0373; NPHP6; Cep290; CT87 [Similar Products]
NCBI Summary for CEP290
This gene encodes a protein with 13 putative coiled-coil domains, a region with homology to SMC chromosome segregation ATPases, six KID motifs, three tropomyosin homology domains and an ATP/GTP motif A. The protein is localized to the centrosome and cilia and has sites for N-glycosylation, tyrosine sulfation, phosphorylation, N-myristoylation, and amidation. Mutations in this gene have been associated with Joubert syndrome and nephronophthisis and the presence of antibodies against this protein is associated with several forms of cancer. [provided by RefSeq, Jul 2008]
UniProt Comments for CEP290
Involved in early and late steps in cilia formation. Its association with CCP110 is required for inhibition of primary cilia formation by CCP110 (PubMed:18694559). May play a role in early ciliogenesis in the disappearance of centriolar satellites and in the transition of primary ciliar vesicles (PCVs) to capped ciliary vesicles (CCVs). Required for the centrosomal recruitment of RAB8A and for the targeting of centriole satellite proteins to centrosomes such as of PCM1 (PubMed:24421332). Required for the correct localization of ciliary and phototransduction proteins in retinal photoreceptor cells; may play a role in ciliary transport processes (). Required for efficient recruitment of RAB8A to primary cilium (PubMed:17705300). In the ciliary transition zone is part of the tectonic-like complex which is required for tissue-specific ciliogenesis and may regulate ciliary membrane composition (). Involved in regulation of the BBSome complex integrity, specifically for presence of BBS2, BBS5 and BBS8/TTC8 in the complex, and in ciliary targeting of selected BBSome cargos. May play a role in controlling entry of the BBSome complex to cilia possibly implicating IQCB1/NPHP5 (PubMed:25552655). Activates ATF4-mediated transcription (PubMed:16682973).
Research Articles on CEP290
1. Together with a physical interaction between RPGR and the C-terminal domain of CEP290, our data suggest that RPGR and CEP290 genetically interact and highlight the involvement of hypomorphic alleles of genes as potential modifiers of heterogeneous retinal ciliopathies.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.